-
1
-
-
0021880212
-
Antineoplastic effects in rats of 5-fluorocytosine in combination with cytosine deaminase capsules
-
Nishiyama T, Kawamura Y, Kawamoto K, et al. Antineoplastic effects in rats of 5-fluorocytosine in combination with cytosine deaminase capsules. Cancer Res 1985;45:1753-1761
-
(1985)
Cancer Res
, vol.45
, pp. 1753-1761
-
-
Nishiyama, T.1
Kawamura, Y.2
Kawamoto, K.3
-
2
-
-
0023518829
-
Implantable enzyme capsules for cancer chemotherapy from bakers' yeast cytosine deaminase immobilized on epoxy-acrylic resin and urethane prepolymer
-
Katsuragi T, Sakai T, Tonomura K. Implantable enzyme capsules for cancer chemotherapy from bakers' yeast cytosine deaminase immobilized on epoxy-acrylic resin and urethane prepolymer. Appl Biochem Biotechnol 1987;16:61-69
-
(1987)
Appl Biochem Biotechnol
, vol.16
, pp. 61-69
-
-
Katsuragi, T.1
Sakai, T.2
Tonomura, K.3
-
3
-
-
0030589523
-
Gene-directed enzyme prodrug therapy (GDEPT): Choice of prodrugs
-
Springer CJ, Niculescu-Duvaz I. Gene-directed enzyme prodrug therapy (GDEPT): choice of prodrugs. Adv Drug Deliv Rev 1996;22:351-364
-
(1996)
Adv Drug Deliv Rev
, vol.22
, pp. 351-364
-
-
Springer, C.J.1
Niculescu-Duvaz, I.2
-
4
-
-
0027523517
-
A first step in the development of gene therapy for colorectal carcinoma: Cloning, sequencing, and expression of Escherichia coli cytosine deaminase
-
Austin EA, Huber BE. A first step in the development of gene therapy for colorectal carcinoma: cloning, sequencing, and expression of Escherichia coli cytosine deaminase. Mol Pharmacol 1993;43:380-387
-
(1993)
Mol Pharmacol
, vol.43
, pp. 380-387
-
-
Austin, E.A.1
Huber, B.E.2
-
5
-
-
0026599586
-
Transfer of the bacterial gene for cytosine deaminase to mammalian cells confers lethal sensitivity to 5-fluorocytosine: A negative selection system
-
Mullen CA, Kilstrup M, Blaese RM. Transfer of the bacterial gene for cytosine deaminase to mammalian cells confers lethal sensitivity to 5-fluorocytosine: a negative selection system. Proc Natl Acad Sci U S A 1992;89:33-37
-
(1992)
Proc Natl Acad Sci U S A
, vol.89
, pp. 33-37
-
-
Mullen, C.A.1
Kilstrup, M.2
Blaese, R.M.3
-
6
-
-
0029995247
-
In vivo replication-deficient adenovirus vector-mediated transduction of the cytosine deaminase gene sensitizes glioma cells to 5-fluorocytosine
-
Dong Y, Wen P, Manome Y, et al. In vivo replication-deficient adenovirus vector-mediated transduction of the cytosine deaminase gene sensitizes glioma cells to 5-fluorocytosine. Hum Gene Ther 1996;7:713-720
-
(1996)
Hum Gene Ther
, vol.7
, pp. 713-720
-
-
Dong, Y.1
Wen, P.2
Manome, Y.3
-
7
-
-
0028108469
-
Metabolism of 5-fluorocytosine to 5-fluorouracil in human colorectal tumor cells transduced with the cytosine deaminase gene: Significant antitumor effects when only a small percentage of tumor cells express cytosine deaminase
-
Huber BE, Austin EA, Richards CA, Davis ST, Good SS. Metabolism of 5-fluorocytosine to 5-fluorouracil in human colorectal tumor cells transduced with the cytosine deaminase gene: significant antitumor effects when only a small percentage of tumor cells express cytosine deaminase. Proc Natl Acad Sci U S A 1994;91:8302-8306
-
(1994)
Proc Natl Acad Sci U S A
, vol.91
, pp. 8302-8306
-
-
Huber, B.E.1
Austin, E.A.2
Richards, C.A.3
Davis, S.T.4
Good, S.S.5
-
8
-
-
0028297316
-
Tumors expressing the cytosine deaminase suicide gene can be eliminated in vivo with 5-fluorocytosine and induce protective immunity to wild type tumor
-
Mullen CA, Coale MM, Lowe R, Blaese RM. Tumors expressing the cytosine deaminase suicide gene can be eliminated in vivo with 5-fluorocytosine and induce protective immunity to wild type tumor. Cancer Res 1994;54:1503-1506
-
(1994)
Cancer Res
, vol.54
, pp. 1503-1506
-
-
Mullen, C.A.1
Coale, M.M.2
Lowe, R.3
Blaese, R.M.4
-
9
-
-
0029943796
-
Monitoring gene therapy with cytosine deaminase: In vitro studies using tritiated-5-fluorocytosine
-
Haberkorn U, Oberdorfer F, Gebert J, et al. Monitoring gene therapy with cytosine deaminase: in vitro studies using tritiated-5-fluorocytosine. J Nucl Med 1996;37:87-94.
-
(1996)
J Nucl Med
, vol.37
, pp. 87-94
-
-
Haberkorn, U.1
Oberdorfer, F.2
Gebert, J.3
-
10
-
-
0032526178
-
Preferential cytotoxicity of cells transduced with cytosine deaminase compared to bystander cells after treatment with 5-fluorocytosine
-
Lawrence TS, Rehemtulla A, Ng EY, Wilson M, Trosko JE, Stetson PL. Preferential cytotoxicity of cells transduced with cytosine deaminase compared to bystander cells after treatment with 5-fluorocytosine. Cancer Res 1998;58:2588-2593
-
(1998)
Cancer Res
, vol.58
, pp. 2588-2593
-
-
Lawrence, T.S.1
Rehemtulla, A.2
Ng, E.Y.3
Wilson, M.4
Trosko, J.E.5
Stetson, P.L.6
-
11
-
-
0027483695
-
The "bystander effect": Tumor regression when a fraction of the tumor mass is genetically modified
-
Freeman SM, Abboud CN, Whartenby KA, et al. The "bystander effect": tumor regression when a fraction of the tumor mass is genetically modified. Cancer Res 1993;53:5274-5283
-
(1993)
Cancer Res
, vol.53
, pp. 5274-5283
-
-
Freeman, S.M.1
Abboud, C.N.2
Whartenby, K.A.3
-
12
-
-
0022485359
-
Tumor sensitivity conferred by inserted herpes thymidine kinase genes: Paradigm for a prospective cancer control strategy
-
Moolten FL. Tumor sensitivity conferred by inserted herpes thymidine kinase genes: paradigm for a prospective cancer control strategy. Cancer Res 1986;46:5276-5281
-
(1986)
Cancer Res
, vol.46
, pp. 5276-5281
-
-
Moolten, F.L.1
-
13
-
-
0031788385
-
Bystander effect caused by cytosine deaminase gene and 5-fluorocytosine in vitro is substantially mediated by generated 5-fluorouracil
-
Kuriyama E, Masui K, Sakamoto T, et al. Bystander effect caused by cytosine deaminase gene and 5-fluorocytosine in vitro is substantially mediated by generated 5-fluorouracil. Anticancer Res 1998;18:3399-3406
-
(1998)
Anticancer Res
, vol.18
, pp. 3399-3406
-
-
Kuriyama, E.1
Masui, K.2
Sakamoto, T.3
-
14
-
-
3142668353
-
Alanine-scanning mutagenesis reveals a cytosine deaminase mutant with altered substrate preference
-
Mahan SD, Ireton GC, Stoddard BL, Black ME. Alanine-scanning mutagenesis reveals a cytosine deaminase mutant with altered substrate preference. Biochemistry 2004;43:8957-8964
-
(2004)
Biochemistry
, vol.43
, pp. 8957-8964
-
-
Mahan, S.D.1
Ireton, G.C.2
Stoddard, B.L.3
Black, M.E.4
-
15
-
-
10844265515
-
Random mutagenesis and selection of Escherichia coli cytosine deaminase for cancer gene therapy
-
Mahan SD, Ireton GC, Knoeber C, Stoddard BL, Black ME. Random mutagenesis and selection of Escherichia coli cytosine deaminase for cancer gene therapy. Protein Eng Des Sel 2004;17:625-633
-
(2004)
Protein Eng des Sel
, vol.17
, pp. 625-633
-
-
Mahan, S.D.1
Ireton, G.C.2
Knoeber, C.3
Stoddard, B.L.4
Black, M.E.5
-
17
-
-
0043133654
-
The 1.14 a crystal structure of yeast cytosine deaminase: Evolution of nucleotide salvage enzymes and implications for genetic chemotherapy
-
Ireton GC, Black ME, Stoddard BL. The 1.14 A crystal structure of yeast cytosine deaminase: evolution of nucleotide salvage enzymes and implications for genetic chemotherapy. Structure 2003;11:961-972
-
(2003)
Structure
, vol.11
, pp. 961-972
-
-
Ireton, G.C.1
Black, M.E.2
Stoddard, B.L.3
-
18
-
-
0032029743
-
Cloning, overexpression, and purification of cytosine deaminase from Saccharomyces cerevisiae
-
Hayden MS, Linsley PS, Wallace AR, Marquardt H, Kerr DE. Cloning, overexpression, and purification of cytosine deaminase from Saccharomyces cerevisiae . Protein Expr Purif 1998;12:173-184
-
(1998)
Protein Expr Purif
, vol.12
, pp. 173-184
-
-
Hayden, M.S.1
Linsley, P.S.2
Wallace, A.R.3
Marquardt, H.4
Kerr, D.E.5
-
19
-
-
40649117959
-
Yeast cytosine deaminase mutants with increased thermostability impart sensitivity to 5-fluorocytosine
-
Stolworty TS, Aaron MK, Candice LW, Ardiani A, Cundiff J, Stoddard BL, Black ME. Yeast cytosine deaminase mutants with increased thermostability impart sensitivity to 5-fluorocytosine. J Mol Biol 2008;377:854-869
-
(2008)
J Mol Biol
, vol.377
, pp. 854-869
-
-
Stolworty, T.S.1
Aaron, M.K.2
Candice, L.W.3
Ardiani, A.4
Cundiff, J.5
Stoddard, B.L.6
Black, M.E.7
-
21
-
-
0028103275
-
The CCP4 Suite: Programs for protein crystallography
-
Collaborative Computational Project, Number 4
-
Collaborative Computational Project, Number 4. The CCP4 Suite: programs for protein crystallography. Acta Crystallogr D Biol Crystallogr 1994;50:760-763
-
(1994)
Acta Crystallogr D Biol Crystallogr
, vol.50
, pp. 760-763
-
-
-
22
-
-
0028800141
-
Enzyme/prodrug gene therapy: Comparison of cytosine deaminase/5- fluorocytosine versus thymidine kinase/ganciclovir enzyme/prodrug systems in a human colorectal carcinoma cell line
-
Trinh QT, Austin EA, Murray DM, Knick VC, Huber BE. Enzyme/prodrug gene therapy: comparison of cytosine deaminase/5-fluorocytosine versus thymidine kinase/ganciclovir enzyme/prodrug systems in a human colorectal carcinoma cell line. Cancer Res 1995;55:4808-4812
-
(1995)
Cancer Res
, vol.55
, pp. 4808-4812
-
-
Trinh, Q.T.1
Austin, E.A.2
Murray, D.M.3
Knick, V.C.4
Huber, B.E.5
-
24
-
-
0033119291
-
Superiority of yeast over bacterial cytosine deaminase for enzyme/prodrug gene therapy in colon cancer xenografts
-
Kievit E, Bershad E, Ng E, et al. Superiority of yeast over bacterial cytosine deaminase for enzyme/prodrug gene therapy in colon cancer xenografts. Cancer Res 1999;59:1417-1421
-
(1999)
Cancer Res
, vol.59
, pp. 1417-1421
-
-
Kievit, E.1
Bershad, E.2
Ng, E.3
-
25
-
-
0029883624
-
Creation of drug-specific herpes simplex virus type 1 thymidine kinase mutants for gene therapy
-
Black ME, Newcomb TG, Wilson HM, Loeb LA. Creation of drug-specific herpes simplex virus type 1 thymidine kinase mutants for gene therapy. Proc Natl Acad Sci U S A 1996;93:3525-3529
-
(1996)
Proc Natl Acad Sci U S A
, vol.93
, pp. 3525-3529
-
-
Black, M.E.1
Newcomb, T.G.2
Wilson, H.M.3
Loeb, L.A.4
-
26
-
-
0036708008
-
Characterization of herpes simplex virus type 1 thymidine kinase mutants engineered for improved ganciclovir or acyclovir activity
-
Kokoris MS, Black ME. Characterization of herpes simplex virus type 1 thymidine kinase mutants engineered for improved ganciclovir or acyclovir activity. Protein Sci 2002;11:2267-2272
-
(2002)
Protein Sci
, vol.11
, pp. 2267-2272
-
-
Kokoris, M.S.1
Black, M.E.2
-
28
-
-
0034547928
-
Yeast cytosine deaminase improves radiosensitization and bystander effect by 5-fluorocytosine of human colorectal cancer xenografts
-
Kievit E, Nyati MK, Ng E, et al. Yeast cytosine deaminase improves radiosensitization and bystander effect by 5-fluorocytosine of human colorectal cancer xenografts. Cancer Res 2000;60:6649-6655
-
(2000)
Cancer Res
, vol.60
, pp. 6649-6655
-
-
Kievit, E.1
Nyati, M.K.2
Ng, E.3
-
29
-
-
0035123128
-
Gene directed enzyme/prodrug therapy of cancer: Historical appraisal and future prospective
-
Greco O, Dachs G. Gene directed enzyme/prodrug therapy of cancer: historical appraisal and future prospective. J Cell Physiol 2001;187:22-36.
-
(2001)
J Cell Physiol
, vol.187
, pp. 22-36
-
-
Greco, O.1
Dachs, G.2
-
30
-
-
0030923831
-
Gene-directed enzyme prodrug therapy: A review of enzyme/prodrug combinations
-
Niculescu-Duvaz I, Springer CJ. Gene-directed enzyme prodrug therapy: a review of enzyme/prodrug combinations. Expert Opin Investig Drugs 1997;6:685-703.
-
(1997)
Expert Opin Investig Drugs
, vol.6
, pp. 685-703
-
-
Niculescu-Duvaz, I.1
Springer, C.J.2
-
31
-
-
54049150469
-
Molecular chemotherapy of pancreatic cancer using novel mutant bacterial cytosine deaminase gene
-
Kaliberova LN, Della Manna DL, Krendelchtchikova V, Black ME, Buchsbaum DJ, Kaleberov SA. Molecular chemotherapy of pancreatic cancer using novel mutant bacterial cytosine deaminase gene. Mol Cancer Ther 2008;7:2845-2854
-
(2008)
Mol Cancer Ther
, vol.7
, pp. 2845-2854
-
-
Kaliberova, L.N.1
Della Manna, D.L.2
Krendelchtchikova, V.3
Black, M.E.4
Buchsbaum, D.J.5
Kaleberov, S.A.6
|